International Journal of Homoeopathic Sciences

Background: Colorectal cancer remains a major global health concern, with survival outcomes dependent on various treatment modalities. While conventional therapies such as surgery, chemotherapy, and radiation are standard, complementary approaches, including homoeopathy, have gained attention. This retrospective study evaluates the impact of homoeopathy as an adjuvant therapy on overall survival in Colorectal cancer patients.
Methods: Conducted at a government cancer center, this study retrospectively analyzed 52 Colorectal cancer patients who received homoeopathy either as a stand-alone treatment or as an adjuvant to conventional therapy. Overall survival was assessed using the Kaplan-Meier survival curve. The primary outcome was the five-year Overall Survival rate.
Results: The analysis revealed that 15.3% of the patients survived beyond five years. Kaplan-Meier survival analysis for the entire cohort (n = 52) demonstrated a mean overall survival of 28.058 months (95% CI: 20.907–35.208) and a median survival of 16.00 months (95% CI: 7.166–24.834
Conclusion: This study suggests a potential role for homoeopathy in influencing Colorectal cancer survival outcomes. While a subset of patients experienced extended survival, further large-scale, controlled studies are necessary to establish the efficacy and mechanism of homoeopathy as an adjuvant therapy in Colorectal cancer management.